The global bioimpedance analyzers market size is projected to reach USD 767 million by 2026 from USD 429 million in 2021, at a CAGR of 10.2% from 2021 to 2026. Growth in this market is driven by the growing prevalence of lifestyle diseases such as obesity, increasing awareness on healthy lifestyles, and the growing number of fitness clubs, weight loss clinics, and sports rehabilitation centers.
Multi-frequency bioimpedance analyzers segment to witness the highest growth during the forecast period.
Based on the product, the bioimpedance analyzers market is segmented into multi-frequency bioimpedance analyzers, single-frequency bioimpedance analyzers, and dual-frequency bioimpedance analyzers. The consumables segment is projected to grow at the highest CAGR during the forecast period. The increasing prevalence of diseases, the growing focus on drug discovery, and the rising R&D expenditure by pharmaceutical companies are the major factor supporting the growth of this segment.
Wireless bioimpedance modality segment to register the highest growth in the bioimpedance analyzers market during the forecast period.
Based on the modality, the bioimpedance analyzers market is segmented into wired bioimpedance analyzers and wireless bioimpedance analyzers. The wireless bioimpedance analyzers segment is projected to witness the highest growth in the bioimpedance analyzers market during the forecast period. The advancements in and the growing demand for wireless technologies are the major factors supporting the growth of this segment.
Asia Pacific is estimated to register the highest CAGR during the forecast period.
In this report, the bioimpedance analyzers market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). The market in Asia Pacific is projected to register the highest growth rate during the forecast period. The growth in this market is primarily driven by the rising obesity rates in China, growing awareness about health and fitness, and the strong foothold of local players in Japan.
Breakdown of supply-side primary interviews, by company type, designation, and region:
- By Company Type: Tier 1 (32%), Tier 2(44%), and Tier 3 (24%)
- By Designation: C-level (30%), Director-level (34%), and Others (36%)
- By Region: North America (40%), Europe (28%), AsiaPacific(20%), and Rest of the World(12%)
List of Companies Profiled in the Report
- Omron Corporation (Japan)
- Tanita Corporation (Japan)
- InBody (South Korea)
- RJL Systems (US),
- seca GmbH & Co. KG (Germany)
- EVOLT 360 (Australia)
- SELVAS Healthcare (South Korea)
- Charder Electronic Co. Ltd. (China)
- Fook Tin Group Holding Ltd. (China)
- Bodystat Ltd. (UK), Maltron International (UK)
- Biotekna (Italy), Withings (France)
- Biodynamics Corporation (US)
- Akern (Italy)
- Xiaomi (China)
- Sino-Hero (Shenzhen)
- Bio-Medical Electronics Co., Ltd. (China)
- Lumsail Industrial Inc. (China)
- Guangzhou Beautylife Electronic Technology Co., Ltd. (China)
- Bioparhom (France)
Research Coverage
This report studies the bioimpedance analyzers market based on product, modality, application,end user,and region. The report also analyzes factors (such as drivers, opportunities, and challenges) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total bioimpedance analyzers market. The report forecasts the revenue of the market segments with respect to five major regions.
Reasons to Buy the Report:
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on bioimpedance analyzers products offered by the top 20 players in the bioimpedance analyzers market. The report analyzes the bioimpedance analyzers market by product, modality,application, end user,and region.
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devices across key geographic regions.
- Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the bioimpedance analyzers market
- Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the bioimpedance analyzers market
What is the estimated value of the Bioimpedance Analyzers Market?
What is the growth rate of the Bioimpedance Analyzers Market?
What is the forecasted size of the Bioimpedance Analyzers Market?
Who are the key companies in the Bioimpedance Analyzers Market?
| Report Attribute | Details |
|---|---|
| No. of Pages | 166 |
| Published | September 2021 |
| Forecast Period | 2021 - 2026 |
| Estimated Market Value ( USD | $ 429 Million |
| Forecasted Market Value ( USD | $ 767 Million |
| Compound Annual Growth Rate | 10.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
Table of Contents
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Inclusions and Exclusions
1.3 Market Scope
1.3.1 Market Segmentation
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Market Stakeholders
2 Research Methodology
2.1 Research Data
Figure 1 Research Design
2.1.1 Secondary Data
2.1.1.1 Secondary Sources
2.1.2 Primary Data
Figure 2 Primary Sources
2.1.2.1 Key Data from Primary Sources
2.1.2.2 Key Industry Insights
Figure 3 Breakdown of Primary Interviews: by Company Type, Designation, and Region
2.2 Market Size Estimation
Figure 4 CAGR Projections: Supply-Side Analysis
Figure 5 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
Figure 6 Data Triangulation Methodology
2.4 Market Share
2.5 Assumptions for the Study
2.6 COVID-19 Specific Assumptions
2.7 Risk Assessment/Factor Analysis
Table 1 Risk Assessment/Factor Analysis
2.8 COVID-19 Health Assessment
2.9 COVID-19 Economic Assessment
2.10 Assessment of the Impact of COVID-19 on the Economic Scenario
3 Executive Summary
Figure 9 Bioimpedance Analyzers Market, by Product, 2021 Vs. 2026 (USD Million)
Figure 10 Bioimpedance Analyzers Market, by Modality, 2021 Vs. 2026 (USD Million)
Figure 11 Bioimpedance Analyzers Market, by Application, 2021 Vs. 2026 (USD Million)
Figure 12 Bioimpedance Analyzers Market, by End-user, 2021 Vs. 2026 (USD Million)
Figure 13 Bioimpedance Analyzers Market, by Region, 2021 Vs. 2026 (USD Million)
4 Premium Insights
4.1 Bioimpedance Analyzers Market Overview
Figure 14 Increasing Incidence of Lifestyle Diseases to Drive Market Growth During the Forecast Period
4.2 Bioimpedance Analyzers Market, by Application
Figure 15 Segmental Body Measurement Segment Accounted for the Largest Market Share in 2020
4.3 North America: Bioimpedance Analyzers Market, by Product and Country, 2020
Figure 16 Multi-Frequency Bioimpedance Analyzers Dominated the North American Market in 2020
4.4 Geographical Snapshot of the Bioimpedance Analyzers Market
Figure 17 China to Register the Highest Growth During the Forecast Period
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
Figure 18 Bioimpedance Analyzers Market: Drivers, Opportunities, and Challenges
5.2.1 Drivers
5.2.1.1 Increasing Prevalence of Lifestyle Diseases
5.2.1.2 Initiatives by Governments and Private Organizations to Promote Healthy Lifestyles
5.2.1.3 Growing Number of Fitness Clubs, Weight Loss Clinics, and Sports Rehabilitation Centers
5.2.2 Opportunities
5.2.2.1 Emerging Markets Across the Asia-Pacific and Latin America
5.2.3 Challenges
5.2.3.1 Inconsistency in the Accuracy of Different Bioimpedance Analyzers
5.3 COVID-19 Impact Analysis
5.4 Ranges/Scenarios
5.4.1 Bioimpedance Analyzers Market
Figure 19 Pessimistic Scenario
Figure 20 Optimistic Scenario
Figure 21 Realistic Scenario
5.5 Value Chain Analysis
Figure 22 Major Value is Added During the Manufacturing & Assembly Phases
5.6 Supply Chain Analysis
Figure 23 Distribution-A Strategy Preferred by Prominent Companies
5.7 Porter's Five Forces Analysis
5.7.1 Threat of New Entrants
5.7.2 Intensity of Competitive Rivalry
5.7.3 Bargaining Power of Buyers
5.7.4 Bargaining Power of Suppliers
5.7.5 Threat of Substitutes
5.8 Technology Analysis
5.9 Regulatory Landscape
Figure 24 510(K) Approval Process
5.10 Patent Analysis
5.11 Trade Analysis
5.11.1 Trade Analysis for Bioimpedance Analyzers
Table 2 Import Data for Bioimpedance Analyzers, by Country, 2016-2020 (USD Million)
Table 3 Export Data for Bioimpedance Analyzers, by Country, 2016-2020 (USD Million)
5.12 Pricing Analysis
Table 4 Price Range for Bioimpedance Analyzers
5.13 Ecosystem Analysis
5.13.1 Role in Ecosystem
Figure 25 Key Players in the Bioimpedance Analyzers Ecosystem
5.14 Trends/Disruptions Impacting Customers’ Businesses
5.14.1 Revenue Shift & Revenue Pockets for Bioimpedance Analyzer Manufacturers
5.14.2 Revenue Shift for Bioimpedance Analyzers
6 Bioimpedance Analyzers Market, by Product
6.1 Introduction
Table 5 Bioimpedance Analyzers Market, by Product, 2017-2019 (USD Million)
Table 6 Bioimpedance Analyzers Market, by Product, 2020-2026 (USD Million)
6.2 Multi-Frequency Bioimpedance Analyzers
6.2.1 Multi-Frequency Bioimpedance Analyzers Segment Dominated the Market in 2020
Table 7 Multi-Frequency Bioimpedance Analyzers Market, by Region, 2017-2019 (USD Million)
Table 8 Multi-Frequency Bioimpedance Analyzers Market, by Region, 2020-2026 (USD Million)
6.3 Single-Frequency Bioimpedance Analyzers
6.3.1 Increasing Obese Population to Drive the Growth of this Market Segment
Table 9 Single-Frequency Bioimpedance Analyzers Market, by Region, 2017-2019 (USD Million)
Table 10 Single-Frequency Bioimpedance Analyzers Market, by Region, 2020-2026 (USD Million)
6.4 Dual-Frequency Bioimpedance Analyzers
6.4.1 Increasing Prevalence of Chronic Disorders to Drive the Growth of this Market Segment
Table 11 Dual-Frequency Bioimpedance Analyzers Market, by Region, 2017-2019 (USD Million)
Table 12 Dual-Frequency Bioimpedance Analyzers Market, by Region, 2020-2026 (USD Million)
7 Bioimpedance Analyzers Market, by Modality
7.1 Introduction
Table 13 Bioimpedance Analyzers Market, by Modality, 2017-2019 (USD Million)
Table 14 Bioimpedance Analyzers Market, by Modality, 2020-2026 (USD Million)
7.2 Wireless Bioimpedance Analyzers
7.2.1 Wireless Bioimpedance Analyzers Accounted for the Largest Share of the Market
Table 15 Wireless Bioimpedance Analyzers Market, by Region, 2017-2019 (USD Million)
Table 16 Wireless Bioimpedance Analyzers Market, by Region, 2020-2026 (USD Million)
7.3 Wired Bioimpedance Analyzers
7.3.1 Benefits of Wired Devices to Drive Their Demand Among End-users
Table 17 Wired Bioimpedance Analyzers Market, by Region, 2017-2019 (USD Million)
Table 18 Wired Bioimpedance Analyzers Market, by Region, 2020-2026 (USD Million)
8 Bioimpedance Analyzers Market, by Application
8.1 Introduction
Table 19 Bioimpedance Analyzers Market, by Application, 2017-2019 (USD Million)
Table 20 Bioimpedance Analyzers Market, by Application, 2020-2026 (USD Million)
8.2 Segmental Body Measurement
8.2.1 Segmental Body Measurement Segment to Dominate the Bioimpedance Analyzers Market During the Forecast Period
Table 21 Bioimpedance Analyzers Market for Segmental Body Measurement, by Region, 2017-2019 (USD Million)
Table 22 Bioimpedance Analyzers Market for Segmental Body Measurement, by Region, 2020-2026 (USD Million)
8.3 Whole-Body Measurement
8.3.1 Increasing Incidence of Metabolic Disorders to Drive the Growth of this Market Segment
Table 23 Bioimpedance Analyzers Market for Whole-Body Measurement, by Region, 2017-2019 (USD Million)
Table 24 Bioimpedance Analyzers Market for Whole-Body Measurement, by Region, 2020-2026 (USD Million)
9 Bioimpedance Analyzers Market, by End-user
9.1 Introduction
Table 25 Bioimpedance Analyzers Market, by End-user, 2017-2019 (USD Million)
Table 26 Bioimpedance Analyzers Market, by End-user, 2020-2026 (USD Million)
9.2 Hospitals
9.2.1 Increasing Awareness of Health and Fitness to Drive the Growth of this End-User Segment
Table 27 Bioimpedance Analyzers Market for Hospitals, by Region, 2017-2019 (USD Million)
Table 28 Bioimpedance Analyzers Market for Hospitals, by Region, 2020-2026 (USD Million)
9.3 Fitness Clubs and Wellness Centers
9.3.1 Fitness Clubs and Wellness Centers Segment to Dominate the Bioimpedance Analyzers Market
Figure 26 US: Number of Health Clubs, 2012-2019
Table 29 Bioimpedance Analyzers Market for Fitness Clubs and Wellness Centers, by Region, 2017-2019 (USD Million)
Table 30 Bioimpedance Analyzers Market for Fitness Clubs and Wellness Centers, by Region, 2020-2026 (USD Million)
9.4 Home Users
9.4.1 Technological Advancements to Drive the Growth of this End-User Segment
Table 31 Bioimpedance Analyzers Market for Home Users, by Region, 2017-2019 (USD Million)
Table 32 Bioimpedance Analyzers Market for Home Users, by Region, 2020-2026 (USD Million)
9.5 Other End-users
Table 33 Bioimpedance Analyzers Market for Other End-users, by Region, 2017-2019 (USD Million)
Table 34 Bioimpedance Analyzers Market for Other End-users, by Region, 2020-2026 (USD Million)
10 Bioimpedance Analyzers Market, by Region
10.1 Introduction
Table 35 Bioimpedance Analyzers Market, by Region, 2017-2019 (USD Million)
Table 36 Bioimpedance Analyzers Market, by Region, 2020-2026 (USD Million)
10.2 North America
Figure 27 North America: Bioimpedance Analyzers Market Snapshot
Table 37 North America: Bioimpedance Analyzers Market, by Country, 2017-2019 (USD Million)
Table 38 North America: Bioimpedance Analyzers Market, by Country, 2020-2026 (USD Million)
Table 39 North America: Bioimpedance Analyzers Market, by Product, 2017-2019 (USD Million)
Table 40 North America: Bioimpedance Analyzers Market, by Product, 2020-2026 (USD Million)
Table 41 North America: Bioimpedance Analyzers Market, by Modality, 2017-2019 (USD Million)
Table 42 North America: Bioimpedance Analyzers Market, by Modality, 2020-2026 (USD Million)
Table 43 North America: Bioimpedance Analyzers Market, by Application, 2017-2019 (USD Million)
Table 44 North America: Bioimpedance Analyzers Market, by Application, 2020-2026 (USD Million)
Table 45 North America: Bioimpedance Analyzers Market, by End-user, 2017-2019 (USD Million)
Table 46 North America: Bioimpedance Analyzers Market, by End-user, 2020-2026 (USD Million)
10.2.1 US
10.2.1.1 Increasing Number of Health Clubs and Fitness Centers Driving Market Growth in the US
Table 47 US: Bioimpedance Analyzers Market, by Product, 2017-2019 (USD Million)
Table 48 US: Bioimpedance Analyzers Market, by Product, 2020-2026 (USD Million)
Table 49 US: Bioimpedance Analyzers Market, by Modality, 2017-2019 (USD Million)
Table 50 US: Bioimpedance Analyzers Market, by Modality, 2020-2026 (USD Million)
Table 51 US: Bioimpedance Analyzers Market, by Application, 2017-2019 (USD Million)
Table 52 US: Bioimpedance Analyzers Market, by Application, 2020-2026 (USD Million)
Table 53 US: Bioimpedance Analyzers Market, by End-user, 2017-2019 (USD Million)
Table 54 US: Bioimpedance Analyzers Market, by End-user, 2020-2026 (USD Million)
10.2.2 Canada
10.2.2.1 High Prevalence of Obesity in Canada to Support Market Growth
Table 55 Canada: Bioimpedance Analyzers Market, by Product, 2017-2019 (USD Million)
Table 56 Canada: Bioimpedance Analyzers Market, by Product, 2020-2026 (USD Million)
Table 57 Canada: Bioimpedance Analyzers Market, by Modality, 2017-2019 (USD Million)
Table 58 Canada: Bioimpedance Analyzers Market, by Modality, 2020-2026 (USD Million)
Table 59 Canada: Bioimpedance Analyzers Market, by Application, 2017-2019 (USD Million)
Table 60 Canada: Bioimpedance Analyzers Market, by Application, 2020-2026 (USD Million)
Table 61 Canada: Bioimpedance Analyzers Market, by End-user, 2017-2019 (USD Million)
Table 62 Canada: Bioimpedance Analyzers Market, by End-user, 2020-2026 (USD Million)
10.3 Europe
Table 63 Europe: Bioimpedance Analyzers Market, by Country, 2017-2019 (USD Million)
Table 64 Europe: Bioimpedance Analyzers Market, by Country, 2020-2026 (USD Million)
Table 65 Europe: Bioimpedance Analyzers Market, by Product, 2017-2019 (USD Million)
Table 66 Europe: Bioimpedance Analyzers Market, by Product, 2020-2026 (USD Million)
Table 67 Europe: Bioimpedance Analyzers Market, by Modality, 2017-2019 (USD Million)
Table 68 Europe: Bioimpedance Analyzers Market, by Modality, 2020-2026 (USD Million)
Table 69 Europe: Bioimpedance Analyzers Market, by Application, 2017-2019 (USD Million)
Table 70 Europe: Bioimpedance Analyzers Market, by Application, 2020-2026 (USD Million)
Table 71 Europe: Bioimpedance Analyzers Market, by End-user, 2017-2019 (USD Million)
Table 72 Europe: Bioimpedance Analyzers Market, by End-user, 2020-2026 (USD Million)
10.3.1 Germany
10.3.1.1 Germany is the Largest Market for Bioimpedance Analyzers in Europe
Table 73 Germany: Bioimpedance Analyzers Market, by Product, 2017-2019 (USD Million)
Table 74 Germany: Bioimpedance Analyzers Market, by Product, 2020-2026 (USD Million)
Table 75 Germany: Bioimpedance Analyzers Market, by Modality, 2017-2019 (USD Million)
Table 76 Germany: Bioimpedance Analyzers Market, by Modality, 2020-2026 (USD Million)
Table 77 Germany: Bioimpedance Analyzers Market, by Application, 2017-2019 (USD Million)
Table 78 Germany: Bioimpedance Analyzers Market, by Application, 2020-2026 (USD Million)
Table 79 Germany: Bioimpedance Analyzers Market, by End-user, 2017-2019 (USD Million)
Table 80 Germany: Bioimpedance Analyzers Market, by End-user, 2020-2026 (USD Million)
10.3.2 UK
10.3.2.1 UK is the Second-Largest Market for Bioimpedance Analyzers in Europe
Table 81 UK: Bioimpedance Analyzers Market, by Product, 2017-2019 (USD Million)
Table 82 UK: Bioimpedance Analyzers Market, by Product, 2020-2026 (USD Million)
Table 83 UK: Bioimpedance Analyzers Market, by Modality, 2017-2019 (USD Million)
Table 84 UK: Bioimpedance Analyzers Market, by Modality, 2020-2026 (USD Million)
Table 85 UK: Bioimpedance Analyzers Market, by Application, 2017-2019 (USD Million)
Table 86 UK: Bioimpedance Analyzers Market, by Application, 2020-2026 (USD Million)
Table 87 UK: Bioimpedance Analyzers Market, by End-user, 2017-2019 (USD Million)
Table 88 UK: Bioimpedance Analyzers Market, by End-user, 2020-2026 (USD Million)
10.3.3 France
10.3.3.1 Increasing Obese Population and Rising Prevalence of Metabolic Disorders to Drive Market Growth in France
Table 89 France: Bioimpedance Analyzers Market, by Product, 2017-2019 (USD Million)
Table 90 France: Bioimpedance Analyzers Market, by Product, 2020-2026 (USD Million)
Table 91 France: Bioimpedance Analyzers Market, by Modality, 2017-2019 (USD Million)
Table 92 France: Bioimpedance Analyzers Market, by Modality, 2020-2026 (USD Million)
Table 93 France: Bioimpedance Analyzers Market, by Application, 2017-2019 (USD Million)
Table 94 France: Bioimpedance Analyzers Market, by Application, 2020-2026 (USD Million)
Table 95 France: Bioimpedance Analyzers Market, by End-user, 2017-2019 (USD Million)
Table 96 France: Bioimpedance Analyzers Market, by End-user, 2020-2026 (USD Million)
10.3.4 Rest of Europe
Table 97 RoE: Bioimpedance Analyzers Market, by Product, 2017-2019 (USD Million)
Table 98 RoE: Bioimpedance Analyzers Market, by Product, 2020-2026 (USD Million)
Table 99 RoE: Bioimpedance Analyzers Market, by Modality, 2017-2019 (USD Million)
Table 100 RoE: Bioimpedance Analyzers Market, by Modality, 2020-2026 (USD Million)
Table 101 RoE: Bioimpedance Analyzers Market, by Application, 2017-2019 (USD Million)
Table 102 RoE: Bioimpedance Analyzers Market, by Application, 2020-2026 (USD Million)
Table 103 RoE: Bioimpedance Analyzers Market, by End-user, 2017-2019 (USD Million)
Table 104 RoE: Bioimpedance Analyzers Market, by End-user, 2020-2026 (USD Million)
10.4 Asia-Pacific
Figure 28 Asia-Pacific: Bioimpedance Analyzers Market Snapshot
Table 105 Asia-Pacific: Bioimpedance Analyzers Market, by Country, 2017-2019 (USD Million)
Table 106 Asia-Pacific: Bioimpedance Analyzers Market, by Country, 2020-2026 (USD Million)
Table 107 Asia-Pacific: Bioimpedance Analyzers Market, by Product, 2017-2019 (USD Million)
Table 108 Asia-Pacific: Bioimpedance Analyzers Market, by Product, 2020-2026 (USD Million)
Table 109 Asia-Pacific: Bioimpedance Analyzers Market, by Modality, 2017-2019 (USD Million)
Table 110 Asia-Pacific: Bioimpedance Analyzers Market, by Modality, 2020-2026 (USD Million)
Table 111 Asia-Pacific: Bioimpedance Analyzers Market, by Application, 2017-2019 (USD Million)
Table 112 Asia-Pacific: Bioimpedance Analyzers Market, by Application, 2020-2026 (USD Million)
Table 113 Asia-Pacific: Bioimpedance Analyzers Market, by End-user, 2017-2019 (USD Million)
Table 114 Asia-Pacific: Bioimpedance Analyzers Market, by End-user, 2020-2026 (USD Million)
10.4.1 Japan
10.4.1.1 Strong Presence of Local Players to Drive Market Growth in Japan
Table 115 Japan: Bioimpedance Analyzers Market, by Product, 2017-2019 (USD Million)
Table 116 Japan: Bioimpedance Analyzers Market, by Product, 2020-2026 (USD Million)
Table 117 Japan: Bioimpedance Analyzers Market, by Modality, 2017-2019 (USD Million)
Table 118 Japan: Bioimpedance Analyzers Market, by Modality, 2020-2026 (USD Million)
Table 119 Japan: Bioimpedance Analyzers Market, by Application, 2017-2019 (USD Million)
Table 120 Japan: Bioimpedance Analyzers Market, by Application, 2020-2026 (USD Million)
Table 121 Japan: Bioimpedance Analyzers Market, by End-user, 2017-2019 (USD Million)
Table 122 Japan: Bioimpedance Analyzers Market, by End-user, 2020-2026 (USD Million)
10.4.2 China
10.4.2.1 Increasing Obese Population to Drive Market Growth in China
Table 123 China: Bioimpedance Analyzers Market, by Product, 2017-2019 (USD Million)
Table 124 China: Bioimpedance Analyzers Market, by Product, 2020-2026 (USD Million)
Table 125 China: Bioimpedance Analyzers Market, by Modality, 2017-2019 (USD Million)
Table 126 China: Bioimpedance Analyzers Market, by Modality, 2020-2026 (USD Million)
Table 127 China: Bioimpedance Analyzers Market, by Application, 2017-2019 (USD Million)
Table 128 China: Bioimpedance Analyzers Market, by Application, 2020-2026 (USD Million)
Table 129 China: Bioimpedance Analyzers Market, by End-user, 2017-2019 (USD Million)
Table 130 China: Bioimpedance Analyzers Market, by End-user, 2020-2026 (USD Million)
10.4.3 Taiwan
10.4.3.1 Increasing Incidence of Lifestyle Diseases to Drive Market Growth in Taiwan
Table 131 Taiwan: Bioimpedance Analyzers Market, by Product, 2017-2019 (USD Million)
Table 132 Taiwan: Bioimpedance Analyzers Market, by Product, 2020-2026 (USD Million)
Table 133 Taiwan: Bioimpedance Analyzers Market, by Modality, 2017-2019 (USD Million)
Table 134 Taiwan: Bioimpedance Analyzers Market, by Modality, 2020-2026 (USD Million)
Table 135 Taiwan: Bioimpedance Analyzers Market, by Application, 2017-2019 (USD Million)
Table 136 Taiwan: Bioimpedance Analyzers Market, by Application, 2020-2026 (USD Million)
Table 137 Taiwan: Bioimpedance Analyzers Market, by End-user, 2017-2019 (USD Million)
Table 138 Taiwan: Bioimpedance Analyzers Market, by End-user, 2020-2026 (USD Million)
10.4.4 Australia
10.4.4.1 Increasing Obese Population to Drive Market Growth in Australia
Table 139 Australia: Bioimpedance Analyzers Market, by Product, 2017-2019 (USD Million)
Table 140 Australia: Bioimpedance Analyzers Market, by Product, 2020-2026 (USD Million)
Table 141 Australia: Bioimpedance Analyzers Market, by Modality, 2017-2019 (USD Million)
Table 142 Australia: Bioimpedance Analyzers Market, by Modality, 2020-2026 (USD Million)
Table 143 Australia: Bioimpedance Analyzers Market, by Application, 2017-2019 (USD Million)
Table 144 Australia: Bioimpedance Analyzers Market, by Application, 2020-2026 (USD Million)
Table 145 Australia: Bioimpedance Analyzers Market, by End-user, 2017-2019 (USD Million)
Table 146 Australia: Bioimpedance Analyzers Market, by End-user, 2020-2026 (USD Million)
10.4.5 Rest of Asia-Pacific
Table 147 Roapac: Bioimpedance Analyzers Market, by Product, 2017-2019 (USD Million)
Table 148 Roapac: Bioimpedance Analyzers Market, by Product, 2020-2026 (USD Million)
Table 149 Roapac: Bioimpedance Analyzers Market, by Modality, 2017-2019 (USD Million)
Table 150 Roapac: Bioimpedance Analyzers Market, by Modality, 2020-2026 (USD Million)
Table 151 Roapac: Bioimpedance Analyzers Market, by Application, 2017-2019 (USD Million)
Table 152 Roapac: Bioimpedance Analyzers Market, by Application, 2020-2026 (USD Million)
Table 153 Roapac: Bioimpedance Analyzers Market, by End-user, 2017-2019 (USD Million)
Table 154 Roapac: Bioimpedance Analyzers Market, by End-user, 2020-2026 (USD Million)
10.5 Rest of the World
Table 155 RoW: Bioimpedance Analyzers Market, by Product, 2017-2019 (USD Million)
Table 156 RoW: Bioimpedance Analyzers Market, by Product, 2020-2026 (USD Million)
Table 157 RoW: Bioimpedance Analyzers Market, by Modality, 2017-2019 (USD Million)
Table 158 RoW: Bioimpedance Analyzers Market, by Modality, 2020-2026 (USD Million)
Table 159 RoW: Bioimpedance Analyzers Market, by Application, 2017-2019 (USD Million)
Table 160 RoW: Bioimpedance Analyzers Market, by Application, 2020-2026 (USD Million)
Table 161 RoW: Bioimpedance Analyzers Market, by End-user, 2017-2019 (USD Million)
Table 162 RoW: Bioimpedance Analyzers Market, by End-user, 2020-2026 (USD Million)
11 Competitive Landscape
11.1 Overview
11.2 Key Player Strategies/Right to Win
Table 163 Overview of Strategies Adopted by Key Players in the Bioimpedance Analyzers Market
11.3 Market Share Analysis
Table 164 Bioimpedance Analyzers Market: Degree of Competition
11.4 Company Evaluation Matrix
11.4.1 Stars
11.4.2 Emerging Leaders
11.4.3 Pervasive Players
11.4.4 Participants
Figure 29 Company Evaluation Matrix: Bioimpedance Analyzers Market
11.5 Company Evaluation Matrix (SMEs/Start-Ups)
11.5.1 Progressive Companies
11.5.2 Starting Blocks
11.5.3 Responsive Companies
11.5.4 Dynamic Companies
Figure 30 Company Evaluation Matrix: Bioimpedance Analyzers Market (SMEs & Start-Ups)
11.6 Company Footprint Analysis
Table 165 Overall Footprint of Companies in the Bioimpedance Analyzers Market
Table 166 Product Footprint of Companies
Table 167 Regional Footprint of Companies
12 Company Profiles
12.1 Key Players
Business Overview, Products/Solutions Offered, Recent Developments, Winning Imperatives, Current Focus and Strategies, Threat from Competition, Right to Win
12.1.1 Omron Corporation
Table 168 Omron Corporation: Business Overview
Figure 31 Omron Corporation: Company Snapshot (2020)
12.1.2 Tanita Corporation
Table 169 Tanita Corporation: Business Overview
12.1.3 Inbody Co. Ltd.
Table 170 Inbody Co. Ltd.: Business Overview
12.1.4 Rjl Systems, Inc.
Table 171 Rjl Systems, Inc.: Business Overview
12.1.5 Seca GmbH & Co. Kg
Table 172 Seca GmbH & Co. Kg: Business Overview
12.1.6 Evolt 360
Table 173 Evolt 360: Business Overview
12.1.7 Selvas Healthcare (Formerly Known as Jawon Medical)
Table 174 Selvas Healthcare: Business Overview
12.1.8 Fook Tin Group Holdings Ltd.
Table 175 Fook Tin Group Holdings Ltd.: Business Overview
12.1.9 Bodystat Ltd.
Table 176 Bodystat Ltd.: Business Overview
12.1.10 Charder Electronic Co. Ltd.
Table 177 Charder Electronic Co. Ltd.: Business Overview
12.1.11 Maltron International
Table 178 Maltron International: Business Overview
Business Overview, Products/Solutions Offered, Recent Developments, Winning Imperatives, Current Focus and Strategies, Threat from Competition, Right to Win Might Not be Captured in Case of Unlisted Companies.
12.2 Start-Ups/SME Players
12.2.1 Biotekna
Table 179 Biotekna: Company Overview
12.2.2 Biodynamics Corporation
Table 180 Biodynamics Corporation: Company Overview
12.2.3 Akern
Table 181 Akern: Company Overview
12.2.4 Withings
Table 182 Withings: Company Overview
12.2.5 Xiaomi
Table 183 Xiaomi: Company Overview
12.2.6 Sino-Hero (Shenzhen) Bio-Medical Electronics Co. Ltd.
Table 184 Sino-Hero (Shenzhen) Bio-Medical Electronics Co. Ltd.: Company Overview
12.2.7 Lumsail Industrial Inc.
Table 185 Lumsail Industrial Inc.: Company Overview
12.2.8 Guangzhou Beautylife Electronic Technology Co. Ltd.
Table 186 Guangzhou Beautylife Electronic Technology Co. Ltd.: Company Overview
12.2.9 Bioparhom
Table 187 Bioparhom: Company Overview
12.2.10 Microlife
Table 188 Microlife: Company Overview
13 Appendix
13.1 Discussion Guide
13.2 Knowledge Store: Subscription Portal
13.3 Available Customizations
13.4 Related Reports
13.5 Author Details
Executive Summary
Companies Mentioned
- Akern
- Biodynamics Corporation
- Bioparhom
- Biotekna
- Bodystat Ltd.
- Charder Electronic Co. Ltd.
- Evolt 360
- Fook Tin Group Holdings Ltd.
- Guangzhou Beautylife Electronic Technology Co. Ltd.
- Inbody Co. Ltd.
- Lumsail Industrial Inc.
- Maltron International
- Microlife
- Omron Corporation
- Rjl Systems, Inc.
- Seca GmbH & Co. Kg
- Selvas Healthcare (Formerly Known as Jawon Medical)
- Sino-Hero (Shenzhen) Bio-Medical Electronics Co. Ltd.
- Tanita Corporation
- Withings
- Xiaomi
Methodology
LOADING...
